Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
With these limits in place, the FDA has deemed that foods such as salmon, avocados, olive oil, and water—yes, water—can now ...
He noted that the FDA approved Xolair (omalizumab) 19 years after it was approved in Europe. In a chapter on HIV being transmitted through blood donations, Makary writes scornfully about the FDA ...
The prospect of Trump officials overturning the approval of FDA-approved medicines is a growing concern for physicians, medical researchers and drugmakers. Mifepristone was approved roughly 25 ...
Marty Makary, MD, MPH, President Trump's nominee for FDA commissioner, seems likely to be a lock for the position if Thursday ...
The FDA approved mifepristone in 2000 with limitations ... in which he says members just "rubber stamp" what international organizations already recommend, and having a transparent meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results